Axonics Inc (NAS:AXNX)
$ 67.22 -0.11 (-0.16%) Market Cap: 3.43 Bil Enterprise Value: 3.13 Bil PE Ratio: 0 PB Ratio: 5.47 GF Score: 83/100

Axonics Inc at Piper Sandler Healthcare Conference Transcript

Dec 01, 2022 / 04:00PM GMT
Release Date Price: $70.87 (+3.49%)
Adam Maeder
Piper Sandler Companies - Analyst

All right. We're going to get started here. Good afternoon, everyone. My name is Adam Maeder. I'm one of the medtech analysts here at Piper Sandler. Very pleased to introduce the next panelists. We have Dan Dearen, President and Chief Financial Officer; and Ray Cohen, CEO from Axonics. Gentlemen, thanks so much for joining us.

Dan Dearen
Axonics, Inc. - President & CFO

Thank you. Thanks for the invite. We appreciate it, and good morning.

Questions & Answers

Adam Maeder
Piper Sandler Companies - Analyst

And good morning. Yeah. Maybe I'm losing track of time here. I guess, it's still technically morning. Guys, so maybe just a good place to start is Q3 results -- so a nice beat and raised quarter. The guidance implies for Q4, I think, $74 million and [change]. I think that's a step-up of about 5% sequentially, quarter over quarter. You had a double-digit step-up sequentially in Q4 last year versus Q3.

So maybe just walk through some of the puts

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot